$ORGO
Organogenesis Holdings Inc. Stock $orgo

$orgo Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000119312519143616 Filed on May 10, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q1
Revenue	$64.95M	$57.12M	$35.53M
YoY Change	49.13%	60.78%	-10.81%
Cost Of Revenue	$19.45M	$16.98M	$14.52M
YoY Change	12.4%	16.93%	9.14%
Gross Profit	$45.50M	$40.14M	$21.01M
YoY Change	73.33%	91.08%	-20.82%
Gross Profit Margin	70.06%	70.27%	59.13%
Selling, General & Admin	$48.96M	$48.89M	$38.17M
YoY Change	29.74%	28.11%	36.54%
% of Gross Profit	107.59%	121.8%	181.67%
Research & Development	$3.864M	$3.371M	$2.824M
YoY Change	88.67%	19.37%	82.08%
% of Gross Profit	8.49%	8.4%	13.44%
Depreciation & Amortization	$859.0K	$902.0K	$872.0K
YoY Change	-1.83%	3.44%
% of Gross Profit	1.89%	2.25%	4.15%
Operating Expenses	$52.82M	$52.26M	$40.99M
YoY Change	22.05%	27.51%	38.93%
Operating Profit	-$7.319M	-$12.12M	-$19.98M
YoY Change	-57.01%	-39.34%	572.53%
Interest Expense	$2.187M	$1.778M	$2.429M
YoY Change	-21.36%	-26.8%	52.58%
% of Operating Profit
Other Income/Expense, Net	-$2.307M	-$3.508M	-$2.479M
YoY Change	-22.01%	41.51%	72.51%
Pretax Income	-$9.626M	-$15.63M	-$22.46M
YoY Change	-51.83%	-30.41%	409.53%
Income Tax	$23.00K	$37.00K	$28.00K
% Of Pretax Income
Net Earnings	-$9.649M	-$15.67M	-$22.49M
YoY Change	-51.78%	-30.34%	-1088.48%
Net Earnings / Revenue	-14.86%	-27.43%	-63.29%
Basic Earnings Per Share
Diluted Earnings Per Share	-$106.0K	-$173.3K	-$10.31K
COMMON SHARES
Basic Shares Outstanding	91.32M	92.01M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.00M	$30.60M	$100.0K
YoY Change	19900.0%	30500.0%	-80.0%
Cash & Equivalents	$20.16M	$30.66M	$918.0K
Short-Term Investments
Other Short-Term Assets	$3.200M	$4.000M	$200.0K
YoY Change	3100.0%	1900.0%	-50.0%
Inventory	$18.72M	$17.97M
Prepaid Expenses
Receivables	$34.16M	$32.51M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$76.15M	$85.06M	$300.0K
YoY Change	37973.0%	28254.0%	-66.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.75M	$39.45M
YoY Change
Goodwill	$25.54M	$25.54M
YoY Change
Intangibles	$23.84M	$24.59M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.040M	$1.072M	$313.2M
YoY Change	-99.67%	-99.66%	1.03%
Total Long-Term Assets	$91.93M	$91.39M	$313.5M
YoY Change	-70.8%	-70.85%	1.03%
TOTAL ASSETS
Total Short-Term Assets	$76.15M	$85.06M	$300.0K
Total Long-Term Assets	$91.93M	$91.39M	$313.5M
Total Assets	$168.1M	$176.5M	$313.8M
YoY Change	-46.64%	-43.77%	0.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$22.28M	$24.58M
YoY Change
Accrued Expenses	$20.68M	$20.40M	$4.800M
YoY Change	282.94%	324.9%	4700.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$300.0K
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$2.400M	$2.300M
YoY Change
Total Short-Term Liabilities	$50.40M	$52.31M	$5.100M
YoY Change	754.22%	925.63%	5000.0%
LONG-TERM LIABILITIES
Long-Term Debt	$39.66M	$39.64M	$0.00
YoY Change
Other Long-Term Liabilities	$6.220M	$5.680M	$10.90M
YoY Change	-42.94%	-47.89%	0.0%
Total Long-Term Liabilities	$45.88M	$45.32M	$10.90M
YoY Change	320.94%	315.73%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$50.40M	$52.31M	$5.100M
Total Long-Term Liabilities	$45.88M	$45.32M	$10.90M
Total Liabilities	$144.9M	$143.9M	$15.90M
YoY Change	767.52%	804.99%	44.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$155.2M	-$145.6M
YoY Change
Common Stock	$178.4M	$178.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	$728.5K	$728.5K
Shareholders Equity	$23.20M	$32.56M	-$37.44M
YoY Change
Total Liabilities & Shareholders Equity	$168.1M	$176.5M	$313.8M
YoY Change	-46.64%	-43.77%	0.84%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$9.649M	-$15.67M	-$22.49M
YoY Change	-51.78%	-30.34%	-1088.48%
Depreciation, Depletion And Amortization	$859.0K	$902.0K	$872.0K
YoY Change	-1.83%	3.44%
Cash From Operating Activities	-$12.11M	-$9.558M	-$4.457M
YoY Change	5666.67%	114.45%	3328.46%
INVESTING ACTIVITIES
Capital Expenditures	-$1.180M	$317.0K	$65.00K
YoY Change		387.69%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.180M	-$317.0K	-$65.00K
YoY Change		387.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.800M	19.13M	3.082M
YoY Change	1455.56%	520.8%	-816.74%
NET CHANGE
Cash From Operating Activities	-12.11M	-9.558M	-4.457M
Cash From Investing Activities	-1.180M	-317.0K	-65.00K
Cash From Financing Activities	2.800M	19.13M	3.082M
Net Change In Cash	-10.49M	9.258M	-1.440M
YoY Change	34866.67%	-742.92%	157.14%
FREE CASH FLOW
Cash From Operating Activities	-$12.11M	-$9.558M	-$4.457M
Capital Expenditures	-$1.180M	$317.0K	$65.00K
Free Cash Flow	-$10.93M	-$9.875M	-$4.522M
YoY Change		118.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q1	us-gaap	Cash Cash	30561000
CY2018Q4	us-gaap	Cash Cash	21291000
CY2019Q1	us-gaap	Assets Current AssetsCurrent	85062000
CY2018Q4	us-gaap	Assets Current AssetsCurrent	71131000
CY2019Q1	us-gaap	Assets Assets	176453000
CY2018Q4	us-gaap	Assets Assets	163678000
CY2019Q1	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	20395000
CY2018Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	20388000
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	52307000
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	56096000
CY2019Q1	us-gaap	Liabilities Liabilities	143894000
CY2018Q4	us-gaap	Liabilities Liabilities	116637000
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	178124000
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	177272000
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-145574000
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-130240000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	32559000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	47041000
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	176453000
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163678000
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12121000
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-19981000
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	19000
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	19000
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	90604107
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	64320931
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-15666000
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-22488000
CY2019Q1	us-gaap	Revenues Revenues	57123000
CY2018Q1	us-gaap	Revenues Revenues	35529000
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	16980000
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	14521000
CY2019Q1	us-gaap	Gross Profit GrossProfit	40143000
CY2018Q1	us-gaap	Gross Profit GrossProfit	21008000
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48893000
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38165000
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3371000
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2824000
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	52264000
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	40989000
CY2018Q1	orgo	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	74000
CY2019Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1862000
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	132000
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3508000
CY2019Q1	us-gaap	Interest Expense InterestExpense	1797000
CY2018Q1	us-gaap	Interest Expense InterestExpense	2429000
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2479000
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15629000
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22460000
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	37000
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	28000
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-15666000
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-22488000
CY2018	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-91730000
CY2019Q1	orgo	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	-628000
CY2018	orgo	Stock Issued During Period Value Extinguishment Of Debt StockIssuedDuringPeriodValueExtinguishmentOfDebt	-42764000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1075000
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-119000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-224000
CY2018	us-gaap	Profit Loss ProfitLoss	-64831000
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	917000
CY2018Q1	us-gaap	Depreciation Depreciation	872000
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1498000
CY2019Q1	us-gaap	Depreciation Depreciation	902000
CY2019Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	15109000
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2474000
CY2019Q1	orgo	Non Cash Interest Expense NonCashInterestExpense	170000
CY2018Q1	orgo	Non Cash Interest Expense NonCashInterestExpense	239000
CY2019Q1	orgo	Non Cash Interest Income NonCashInterestIncome	19000
CY2018Q1	orgo	Non Cash Interest Income NonCashInterestIncome	20000
CY2019Q1	orgo	Non Cash Rent Expense Income NonCashRentExpenseIncome	49000
CY2018Q1	orgo	Non Cash Rent Expense Income NonCashRentExpenseIncome	14000
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	224000
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	317000
CY2018Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	73000
CY2019Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1862000
CY2018Q1	orgo	Fair Value Adjustment Of Forfeiture Rights FairValueAdjustmentOfForfeitureRights	589000
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7547000
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5339000
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2282000
CY2019Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	102000
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	114000
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32509000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34077000
CY2019Q1	us-gaap	Inventory Net InventoryNet	17972000
CY2018Q4	us-gaap	Inventory Net InventoryNet	13321000
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3918000
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2328000
CY2019Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	2337000
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	2236000
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	24575000
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19165000
CY2019Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	30984000
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	26484000
CY2019Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	179000
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	130000
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	15418000
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5680000
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5931000
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	9000
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	9000
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39454000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39623000
CY2019Q1	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	496000
CY2018Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	477000
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24592000
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26091000
CY2019Q1	us-gaap	Goodwill Goodwill	25539000
CY2018Q4	us-gaap	Goodwill Goodwill	25539000
CY2019Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	238000
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	238000
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1072000
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	579000
CY2019Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5000000
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5000000
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	963000
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1352000
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4882000
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9706000
CY2019Q1	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	176000
CY2018Q1	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-789000
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-252000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7260387
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	129000
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9558000
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4457000
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	317000
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	65000
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-317000
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-65000
CY2019Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	4500000
CY2018Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	3075000
CY2019Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	811000
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19133000
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3082000
CY2019Q1	us-gaap	Interest Paid InterestPaid	1627000
CY2018Q1	us-gaap	Interest Paid InterestPaid	2190000
CY2019Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	58000
CY2018Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000
CY2019Q1	orgo	Non Cash Purchase Of Property Plant And Equipment NonCashPurchaseOfPropertyPlantAndEquipment	415000
CY2018Q1	orgo	Non Cash Purchase Of Property Plant And Equipment NonCashPurchaseOfPropertyPlantAndEquipment	715000
CY2019Q1	orgo	Working Capital WorkingCapital	32755000
CY2019Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	35801000
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	37497000
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3292000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3420000
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	32509000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34077000
CY2018	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-962000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3420000
CY2019Q1	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-52000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3225000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7266715
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.91
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	6328
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.93
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.91
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.39
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1571000
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M13D
CY2019Q1	us-gaap	Secured Debt SecuredDebt	635000
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3026000
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4959000
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	4386000
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1774000
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	23448000
CY2019Q1	orgo	Accrued Legal Expenses AccruedLegalExpenses	1000000
CY2018	orgo	Adjustments To Additional Paid In Capital Recapitalization Cost AdjustmentsToAdditionalPaidInCapitalRecapitalizationCost	-11206000
CY2019Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	17585000
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3292000
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1157000
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6865000
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4711000
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1440000
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1759000
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9667000
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	917000
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20395000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20388000
CY2019Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	881000
CY2018Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	660000
CY2019Q1	orgo	Business Combination Contingent Consideration Liability Accrued Interest BusinessCombinationContingentConsiderationLiabilityAccruedInterest	692000
CY2018Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2545000
CY2018Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	12578000
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6851000
CY2019Q1	us-gaap	Inventory Net InventoryNet	17972000
CY2018Q4	us-gaap	Inventory Net InventoryNet	13321000
CY2019Q1	orgo	Inventory Reserve Charged To Cost Of Goods Sold InventoryReserveChargedToCostOfGoodsSold	520000
CY2018Q1	orgo	Inventory Reserve Charged To Cost Of Goods Sold InventoryReserveChargedToCostOfGoodsSold	1482000
CY2019Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2836000
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2951000
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	79552000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	79097000
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	63337000
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	62435000
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39454000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	39623000
CY2019Q1	us-gaap	Depreciation Depreciation	902000
CY2018Q1	us-gaap	Depreciation Depreciation	872000
CY2019Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36580000
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11988000
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24592000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	36580000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10489000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26091000
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1498000
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91316039
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91261413
CY2018	orgo	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	-2707000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-15317000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	47041000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	32559000
CY2018Q1	orgo	Offering Costs OfferingCosts	270000
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	44000
CY2018Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9000
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9258000
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 18pt;text-indent: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 6pt;text-indent: 0.79in;"><div style="font-family: "times new roman", serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported results of operations during the reporting period. Actual results could differ from those estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-76000
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	15472000
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	15218000
CY2018Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5000000
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0273
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M20D
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.420
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	5.99
CY2018Q1	orgo	Fair Value Of Common Share FairValueOfCommonShare	5.82
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	266000
CY2019Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	365000
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	963000
CY2019Q1	orgo	Number Of Shares Issues As Collateral For Secured Debt NumberOfSharesIssuesAsCollateralForSecuredDebt	675990
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	17446000
CY2019Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	15109000
CY2019Q1	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	43850000
CY2019Q1	orgo	Capital Lease Amount Of Minimum Rental Payments Increase In Each Year In Ten Year Option To Extend CapitalLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInTenYearOptionToExtend	44000
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	39635000
CY2019Q1	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	496000
CY2018Q1	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	477000
CY2019Q1	orgo	Accrued Interest Notes Receivable AccruedInterestNotesReceivable	19000
CY2018Q1	orgo	Accrued Interest Notes Receivable AccruedInterestNotesReceivable	19000
CY2019Q1	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	21000
CY2019Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	62000
CY2018Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	60000
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1180000
CY2019Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four And Five Years OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears	8123000
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	3231000
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	4308000
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	4308000
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	4738000
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments1 CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1	26148000
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	8702000
CY2019Q1	orgo	Capital Lease Amount Of Minimum Rental Payments Increase In Each Year In Five Year Option To Extend CapitalLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInFiveYearOptionToExtend	33000
CY2019Q1	us-gaap	Security Deposit SecurityDeposit	526000
CY2019Q1	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	263000
CY2019Q1	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	332000
CY2019Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	40000000
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	209000
CY2019Q1	us-gaap	Stock Issued1 StockIssued1	628000
CY2018Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	18000
CY2018Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10000
CY2019Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	33371464
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	33432421
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2019Q1	us-gaap	Line Of Credit LineOfCredit	30984000
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	26484000
CY2019Q1	us-gaap	Long Term Debt LongTermDebt	40000000
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	39635000
CY2018Q4	us-gaap	Notes Payable NotesPayable	15885000
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	762000
CY2018Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2545000
CY2018Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	12578000
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	12222000
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	13333000
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	13333000
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1112000
CY2019Q1	us-gaap	Long Term Debt LongTermDebt	40000000
CY2019Q1	us-gaap	Revenues Revenues	57123000
CY2018Q1	us-gaap	Revenues Revenues	35529000
CY2019Q1	us-gaap	Line Of Credit Facility Covenant Terms LineOfCreditFacilityCovenantTerms	Borrower’s achievement of trailing twelve month revenue of at least $221,250 and a trailing three month EBITDA (as defined in the New Credit Agreement) loss not in excess of $5,000;
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	728548
CY2019Q1	us-gaap	Debt Instrument Description Of Variable Rate Basis DebtInstrumentDescriptionOfVariableRateBasis	interest rate equal to 3.75% above the Wall Street Journal Prime Rate
CY2019Q1	orgo	Additional Payment In Aggregate Of The Principal Amount Percentage AdditionalPaymentInAggregateOfThePrincipalAmountPercentage	0.0625
CY2019Q1	orgo	Percentage Available For Revolving Commitments PercentageAvailableForRevolvingCommitments	0.25
CY2019Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0025
CY2018Q4	orgo	Redeemable Common Stock Liability RedeemableCommonStockLiability	6762000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33976000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33953000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	33178000
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	28547000
CY2018Q1	orgo	Increase Decrease In Accrued Interest Of Affiliate Debt IncreaseDecreaseInAccruedInterestOfAffiliateDebt	-797000
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1440000
CY2018	us-gaap	Debt Instrument Covenant Description DebtInstrumentCovenantDescription	maintain Minimum Liquidity (as defined in the New Credit Agreement) equal to the greater of (i) 6 months Monthly Burn (as defined in the New Credit Agreement) and (ii) $10,000.
CY2019Q1	orgo	Provision For Inventory Reserve ProvisionForInventoryReserve	520000
CY2018Q1	orgo	Provision For Inventory Reserve ProvisionForInventoryReserve	1482000
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-76000
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-208000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-15666000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-22488000
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5668574
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6976993
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.54
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.83
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y10M20D
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y7M24D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y6M10D
CY2019Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	113000
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30663000
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	918000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21405000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2358000
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	92044587
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91261413
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001661181
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019Q1	dei	Trading Symbol TradingSymbol	ORGO
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2019Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	91316039
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0
CY2019Q1	orgo	Redemption Of Redeemable Common Stock RedemptionOfRedeemableCommonStock	-6762000
CY2019Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin: 0.25in 0in 0.0001pt; font-family: "times new roman", serif; font-size: 10pt; text-indent: 0.79in;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Reclassification of Prior Period Balances</div></div><div style="background: none;;font-weight:bold;display:inline;"> </div></div><div style="margin: 6pt 0in 0.0001pt; text-indent: 0.79in; font-family: "times new roman", serif; font-size: 10pt;">Reclassifications have been made to prior period amounts to conform to the current-year presentation of the reporting of deferred interest and principal on outstanding capital lease obligations and deferred tenant escalations as long-term liabilities on the consolidated balance sheets. The deferred interest and tenant escalation amounts were previously reported as accrued expenses on the consolidated balance sheets and the deferred principal on the capital lease obligations were recorded as part of the current portion of capital lease obligations on the consolidated balance sheet. These reclassifications have no effect on the reported net loss or net equity for the years ended March 31, 2019 and December 31, 2018.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4923000
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5170000
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24938461
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9555490
CY2019Q1	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	9563000
CY2019Q1	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	5579000
CY2018Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	5265000
CY2019Q1	us-gaap	Other Liabilities OtherLiabilities	773000
CY2018Q4	us-gaap	Other Liabilities OtherLiabilities	854000
CY2019Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	52000
CY2019Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	52000
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	Organogenesis Holdings Inc.

Files In Submission

Name	View Source	Status
0001193125-19-143616-index-headers.html	Edgar Link	pending
0001193125-19-143616-index.html	Edgar Link	pending
0001193125-19-143616.txt	Edgar Link	pending
0001193125-19-143616-xbrl.zip	Edgar Link	pending
d730852d10q.htm	Edgar Link	pending
d730852dex311.htm	Edgar Link	pending
d730852dex312.htm	Edgar Link	pending
d730852dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
orgo-20190331.xml	Edgar Link	completed
orgo-20190331.xsd	Edgar Link	pending
orgo-20190331_cal.xml	Edgar Link	unprocessable
orgo-20190331_def.xml	Edgar Link	unprocessable
orgo-20190331_lab.xml	Edgar Link	unprocessable
orgo-20190331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGO
Organogenesis Holdings Inc. Stock $orgo

2019 Q2 Form 10-Q Financial Statement

#000119312519143616 Filed on May 10, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO Organogenesis Holdings Inc. Stock $orgo

2019 Q2 Form 10-Q Financial Statement

#000119312519143616 Filed on May 10, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO
Organogenesis Holdings Inc. Stock $orgo